News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
89,282 Results
Type
Article (1864)
Company Profile (17)
Press Release (87401)
Section
Business (36576)
Career Advice (50)
Deals (5801)
Drug Delivery (3)
Drug Development (10901)
Employer Resources (1)
FDA (1598)
Job Trends (1885)
News (52996)
Policy (2986)
Tag
Academia (134)
Accelerated approval (3)
Adcomms (1)
Allergies (18)
Alliances (3519)
ALS (13)
Alzheimer's disease (156)
Antibody-drug conjugate (ADC) (18)
Approvals (1637)
Artificial intelligence (21)
Autoimmune disease (3)
Automation (1)
Bankruptcy (19)
Best Places to Work (1781)
Biosimilars (17)
Biotechnology (15)
Bladder cancer (23)
Brain cancer (2)
Breast cancer (71)
Cancer (472)
Cardiovascular disease (41)
Career advice (43)
Career pathing (4)
CAR-T (24)
CDC (11)
Cell therapy (50)
Cervical cancer (3)
Clinical research (9798)
Collaboration (72)
Compensation (81)
Complete response letters (2)
COVID-19 (254)
CRISPR (3)
C-suite (29)
Cystic fibrosis (5)
Data (701)
Depression (15)
Diabetes (60)
Diagnostics (993)
Digital health (5)
Diversity, equity & inclusion (2)
Drug discovery (13)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (30)
Earnings (30971)
Employer resources (2)
Events (12827)
Executive appointments (58)
FDA (2046)
Frontotemporal dementia (2)
Funding (70)
Gene editing (4)
Gene therapy (38)
GLP-1 (108)
Government (234)
Guidances (243)
Healthcare (2417)
HIV (5)
Huntington's disease (1)
IgA nephropathy (10)
Immunology and inflammation (19)
Immuno-oncology (2)
Indications (3)
Infectious disease (281)
Inflammatory bowel disease (23)
Influenza (13)
Intellectual property (19)
Interviews (4)
IPO (4309)
IRA (4)
Job creations (197)
Job search strategy (35)
Kidney cancer (3)
Labor market (7)
Layoffs (27)
Leadership (1)
Legal (531)
Liver cancer (9)
Longevity (2)
Lung cancer (87)
Lymphoma (49)
Machine learning (1)
Manufacturing (34)
MASH (28)
Medical device (2162)
Medtech (2164)
Mergers & acquisitions (1627)
Metabolic disorders (130)
Multiple sclerosis (12)
NASH (4)
Neurodegenerative disease (15)
Neuropsychiatric disorders (2)
Neuroscience (263)
NextGen: Class of 2025 (607)
Non-profit (275)
Now hiring (4)
Obesity (37)
Opinion (8)
Ovarian cancer (15)
Pain (17)
Pancreatic cancer (15)
Parkinson's disease (20)
Patents (38)
Patient recruitment (30)
Peanut (12)
People (4008)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase I (2597)
Phase II (4128)
Phase III (3701)
Pipeline (987)
Policy (14)
Postmarket research (340)
Preclinical (805)
Press Release (10)
Prostate cancer (30)
Radiopharmaceuticals (39)
Rare diseases (51)
Real estate (327)
Regulatory (2520)
Reports (9)
Research institute (116)
Resumes & cover letters (8)
Rett syndrome (3)
RSV (13)
Schizophrenia (21)
Series A (10)
Series B (9)
Sickle cell disease (6)
Spinal muscular atrophy (18)
Startups (139)
Stomach cancer (2)
Supply chain (6)
Tariffs (4)
The Weekly (2)
Vaccines (111)
Venture capital (3)
Weight loss (28)
Women's health (2)
Worklife (4)
Date
Last 7 days (50)
Last 30 days (230)
Last 365 days (5137)
2025 (3926)
2024 (5895)
2023 (7083)
2022 (8154)
2021 (9633)
2020 (8675)
2019 (5964)
2018 (4500)
2017 (4578)
2016 (3225)
2015 (4951)
2014 (3087)
2013 (1630)
2012 (1979)
2011 (2452)
2010 (2226)
Location
Africa (59)
Alabama (6)
Arizona (18)
Asia (6810)
Australia (882)
California (1484)
Canada (550)
China (91)
Colorado (71)
Connecticut (66)
Delaware (52)
Europe (10476)
Florida (207)
Georgia (40)
Idaho (2)
Illinois (78)
India (1)
Indiana (132)
Japan (43)
Kansas (29)
Kentucky (18)
Louisiana (6)
Maine (14)
Maryland (222)
Massachusetts (1001)
Michigan (34)
Minnesota (78)
Missouri (20)
Montana (11)
Nebraska (2)
Nevada (10)
New Hampshire (10)
New Jersey (482)
New York (536)
North Carolina (178)
Northern California (698)
Ohio (28)
Oklahoma (1)
Oregon (3)
Pennsylvania (373)
Puerto Rico (10)
Rhode Island (1)
South America (120)
South Carolina (1)
Southern California (620)
Tennessee (7)
Texas (210)
United States (5526)
Utah (57)
Virginia (47)
Washington D.C. (6)
Washington State (125)
Wisconsin (7)
89,282 Results for "64".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Plasmid Purification Market Grows at 11.64% CAGR, Expected to Soar USD 5.88 Billion by 2034
October 8, 2025
·
1 min read
Press Releases
Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook
October 9, 2025
·
2 min read
Press Releases
PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
October 16, 2025
·
3 min read
Press Releases
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
October 15, 2025
·
6 min read
Press Releases
64x Bio Launches AAV Apex Suite to Power the Next Generation of Gene Therapy Manufacturing
June 16, 2025
·
2 min read
Press Releases
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
August 28, 2025
·
19 min read
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Viral Vector Manufacturing Market Growth Accelerates with 21.64% CAGR, Fueled by Merck’s $600 Mn Acquisition and NSW’s $49.6 Mn Facility Investment
July 7, 2025
·
1 min read
Press Releases
Bipolar Disorder Mood Stabilizers Market to Reach USD 2.64 Billion by 2032, Backed by Advances in Mood Stabilizing Drug Development
May 13, 2025
·
1 min read
Press Releases
mRNA Therapeutics Market Size to Worth USD 42.64 Billion by 2034
February 26, 2025
·
1 min read
1 of 8,929
Next
